Innate immunity in myasthenia gravis thymus: Pathogenic effects of Toll-like receptor 4 signaling on autoimmunity-Reference-Cited by-同舟云学术

Innate immunity in myasthenia gravis thymus: Pathogenic effects of Toll-like receptor 4 signaling on autoimmunity

Published:2014-08 Issue: Volume:52 Page:74-89
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Cordiglieri Chiara,Marolda Roberta,Franzi Sara,Cappelletti Cristina,Giardina Carmelo,Motta Teresio,Baggi Fulvio,Bernasconi Pia,Mantegazza Renato,Cavalcante Paola

Funder

European Union FIGHT-MG

Italian Ministry of Health

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference68 articles.

1. Autoimmune mechanisms in myasthenia gravis;Cavalcante;Curr Opin Neurol,2012

2. The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes;Marx;Autoimmun Rev,2013

3. The thymus in myasthenia gravis: site of “innate autoimmunity”?;Cavalcante;Muscle Nerve,2011

4. Increased toll-like receptor 4 expression in thymus of myasthenic patients with thymitis and thymic involution;Bernasconi;Am J Pathol,2005

5. Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis;Cufi;Ann Neurol,2013

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of regulatory T cells in pathogenesis and therapeutics of myasthenia gravis;Regulatory T Cells and Autoimmune Diseases;2024

2. Muscle and Muscle-like Autoantigen Expression in Myasthenia Gravis Thymus: Possible Molecular Hint for Autosensitization;Biomedicines;2023-02-28

3. Poor responses and adverse outcomes of myasthenia gravis after thymectomy: Predicting factors and immunological implications;Journal of Autoimmunity;2022-10

4. Is Myasthenia Gravis a Real Complication of the COVID-19 Vaccine? A Case Report-Based Systematic Review;Canadian Journal of Infectious Diseases and Medical Microbiology;2022-09-17

5. Long Non-Coding RNAs in the Cell Fate Determination of Neoplastic Thymic Epithelial Cells;Frontiers in Immunology;2022-04-22